Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells

Nature Medicine

Volumn 3, Issue 2, 1997, Pages 171-176

  Fernanda Ledda, M ^a,b   Adris, Soraya ^a   Bravo, Alicia I ^c   Kairiyama, Claudia ^a   Bover, Laura ^a   Chernajovsky, Yuti ^d   Mordoh, Jose ^a   Podhajcer, Osvaldo L ^a,b  

^a FUNDACIÓN INSTITUTO LELOIR   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c Hospital Eva Peron   (Argentina)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; GLYCOPROTEIN; OSTEONECTIN;

ANIMAL EXPERIMENT; ARTICLE; CANCER INHIBITION; CANCER INVASION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL ADHESION; CELL DIVISION; CELL MOVEMENT; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; MELANOMA, EXPERIMENTAL; MICE; OLIGONUCLEOTIDES, ANTISENSE; OSTEONECTIN; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0031056656     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0297-171     Document Type: Article

References (14)

1. Stetler-Stevenson, W.G., Aznavoorian, S. & Liotta, L.A. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9, 541-573 (1993).
2. Stetler-Stevenson, W.G., Liotta, LA. & Kleiner, D.E. Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J. 7, 1434-1441 (1993).
3. Albelda, S.M. Role of integrins and other cell adhesion molecules in tumor progression and metastasis, Lab. Invest. 68, 4-17 (1993).
4. Wewer, U.M., Taraboletti, G., Sobel, M.E., Albrechtsen, R. & Liotta, L.A. Role of laminin receptors in tumor cell migration. Cancer Res. 47, 5691-5698 (1987).
5. Lane, T.F. & Sage, E.H. The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J. 8, 163-173 (1994).
6. Sage, E.H. & Bornstein, P. Extracellular proteins that modulate cell-matrix interactions. J. Biol. Chem. 266, 14831-14834 (1991).
7. Tremble, P.M., Lane, T.F., Sage, E.H. & Werb, Z. SPARC, a secreted protein associated with morphogenesis and tissue remodelling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway. J. Cell Biol. 121, 1433-1444 (1993).
8. Porter, P.L., Sage, E.H., Lane, T.F., Funk, S.H. & Gown, A.M. Distribution of SPARC in normal and neoplastic tissue, J. Histochem. Cytochem. 43, 791-800 (1995).
9. Podhajcer, O.L. et al. Comparative expression of the SPARC and stromelysin-3 genes in mammary tumors. Breast 5, 13-20 (1996).
10. Bellahcene, A. & Castronovo, V. Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer. Am. J. Pathol. 146, 95-100 (1995).
11. Porte, H. et al. Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40/SPARC genes. Int. J. Cancer 64, 70-75 (1995).
12. Ledda, F. et al. The expression of the secreted protein acidic and rich in cysteine, SPARC, is associated with the neoplastic progression of human melanoma. J. Invest. Dermatol. (in the press).
13. Podhajcer, O.L. et al. Expression of cathepsin D in primary and metastatic human melanoma and dysplastic nevi. J. Invest. Dermatol. 104, 340-144 (1995).
14. Terranova, V.P., Williams, J.E., Liotta, L.E. & Martin, C.R. Modulation of the metastatic activity of melanoma cells by laminin and fibronectin. Science 226, 982-985 (1984).